PNPLA3 and metabolic dysfunction-associated steatohepatitis: Possibly due to overexpression of PNPLA3 parenchymal and nonparenchymal cell interactions starts and may affect features of metabolic disorder through lipid accumulation and modulating fat content in NASH condition.